byiShook Opinion
Dec 19, 2024 - 12:05
Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide — which sells as a weight-loss drug — is no longer in shortage. The post IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List appeared first on Investor's Business Daily.
Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide â which sells as a weight-loss drug â is no longer in shortage.
The post IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List appeared first on Investor's Business Daily.